Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?

Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?

Submitted by admin on June 20, 2019 - 10:04am
Source: 
Biopharma Dive
News Tags: 
Sanofi
M&A
Bioverativ
hemophilia
gene therapy
Headline: 
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
snippet: 

Gene therapies and other long-acting treatments are threatening to outdate the drugs Sanofi got from its Bioverativ deal.

Do Not Allow Advertisers to Use My Personal information